05.06.2013 Views

PNNL-13501 - Pacific Northwest National Laboratory

PNNL-13501 - Pacific Northwest National Laboratory

PNNL-13501 - Pacific Northwest National Laboratory

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Study Control Number: PN99036/1364<br />

Isoprostane-Mediated Tumor Promotion<br />

Thomas J. Weber<br />

Exposure to radiation has been associated with life-span shortening and cancer. The response of a living organism to<br />

radiation can be modified by many factors. The toxic response to ionizing radiation, as well as to numerous chemical<br />

contaminants at DOE sites, is associated with the generation of an oxidative stress. However, the cellular and molecular<br />

mechanisms underlying the carcinogenic response to reactive oxygen species is not known.<br />

Project Description<br />

The toxic response to ionizing radiation, as well as<br />

numerous contaminants identified on DOE sites, is<br />

consistently associated with the generation of an oxidative<br />

stress. Thus, defining the effects of oxidative stress in<br />

mammalian systems is of central interest to DOE.<br />

Oxidative stress is known to play a role in physiologic<br />

and pathophysiologic processes such as cancer, aging, and<br />

neuronal degeneration. It is not clear whether low-level<br />

environmental exposure to radiation sources, or toxicants<br />

whose mechanism of action includes an oxidative stress<br />

component, will increase the risk of cancer.<br />

In the present study, we have investigated whether<br />

prototypical isoprostanes modulate anchorage-dependent<br />

and -independent growth of several in vitro model<br />

systems as an index of tumor promoting activity. We<br />

have found that the isoprostanes modulate anchoragedependent<br />

and -independent growth at extremely low<br />

concentrations (pM-nM), suggesting the biological<br />

activity of these compounds is physiologically relevant.<br />

Introduction<br />

Oxygen free radicals have been implicated in the<br />

pathophysiology of a number of human diseases,<br />

including cancer, atherosclerosis, neurodegenerative<br />

disorders, and aging. Oxidative stress is also central to<br />

the adverse effects of ionizing radiation. Recent<br />

experimental evidence indicates that arachidonic acid may<br />

be converted by reactive oxygen species into a new class<br />

of oxidized lipid metabolites, termed the isoprostanes. In<br />

several model systems, the isoprostanes have been shown<br />

to be biologically active and coupled to signal<br />

transduction pathways associated with carcinogenic<br />

processes. Therefore, it will be important to determine<br />

whether the formation of isoprostanes in response to<br />

ionizing radiation and other environmental associated<br />

toxic insults may increase cancer risk.<br />

The isoprostanes have been shown to signal through the<br />

inositol phospholipid/protein kinase C pathway, which in<br />

turn, is widely implicated in carcinogenic processes.<br />

Thus, the isoprostanes may represent a novel class of<br />

physiologically relevant tumor promoters.<br />

To test this hypothesis, we conducted preliminary studies<br />

to determine whether isoprostanes exhibit tumor<br />

promoting activity using an in vitro model of tumor<br />

promotion (JB6 cell). In addition, we have investigated<br />

whether prototypical isoprostanes modulate anchoragedependent<br />

and -independent growth of several in vitro<br />

model systems as an index of tumor promoting activity.<br />

We have found that the isoprostanes modulate anchoragedependent<br />

and -independent growth at extremely low<br />

concentrations (pM-nM), suggesting the biological<br />

activity of these compounds is physiologically relevant.<br />

Results and Accomplishments<br />

We previously showed that 8-iso-PGF2α increased the<br />

anchorage-independent growth of JB6 cells. We have<br />

extended our investigation to several other in vitro model<br />

systems and a second prototypical isoprostane (8-iso-<br />

PGE2) to determine whether the biological activity of the<br />

isoprostanes was generalizable. Increasing experimental<br />

evidence indicates that vascular smooth muscle cells are<br />

responsive to isoprostanes, and the biological response<br />

isoprostanes may be mediated by a thromboxane A2<br />

(TXA2) receptor (TP), or a putative novel isoprostane<br />

receptor. Studies were conducted to determine whether<br />

8-iso-PGF2α and DDM-PGE2 modulate the proliferation<br />

of smooth muscle cells in vitro. Rat aortic smooth muscle<br />

cells were treated with a range of prostanoid<br />

concentrations and cell proliferation determined using a<br />

picogreen DNA quantitation assay and multiwell<br />

fluorescent plate reader (Cytofluor 4000) according to<br />

manufacturer’s directions. DNA synthesis was increased<br />

in a concentration-dependent fashion by 8-iso-PGF2α, but<br />

Biosciences and Biotechnology 81

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!